ResultsIQ

ResultsIQ › Latest results › India Pesticides Limited

India Pesticides Limited Q2 FY27 results deck summary

NSE: IPL · BSE: 543311

Results deck of 4 Nov 2026, summarised by AI from the filing.

Q2 FY27 total income fell to ₹231 cr (-21.6% YoY) and PAT to ₹18 cr, with two more Hamirpur blocks due in FY2027.

Key takeaways

  1. Q2 FY27 result Total income fell to ₹231 cr (Q2 FY26: ₹295 cr, -21.6%) and PAT to ₹18 cr (₹32 cr, -41.7%) on softer demand and lower herbicide use.
  2. Hamirpur blocks Two additional Hamirpur blocks are to be operational in FY2027, adding to the two of ten already running.
  3. Registrations IPL received UK Technical Equivalence approval for an insecticide and an Argentina herbicide registration in Q2 FY27.
  4. Export orders Management says the company has received good export orders for the coming quarter.

Original filing on BSE

India Pesticides Limited Q2 FY27 results

As filed: Revenue ₹229 cr (−21% year on year), EBITDA ₹30.6 cr (−38% year on year), PAT ₹18.4 cr (−42% year on year), EBITDA margin 13.4% (−345 bps).

The Q2 FY27 score, against the company's own trend, is for premium members.

Earlier results and the share price after them

  • Q1 FY27: Revenue ₹252 cr (−8% year on year), EBITDA ₹35.5 cr (−21% year on year), PAT ₹22.8 cr (−35% year on year), EBITDA margin 14.1% (−227 bps). Score 24 of 100, Below trend. Revenue growth was well below the company's own trend; EBITDA and profit growth were below it. EBITDA margin fell 227 bps year on year. Revenue fell 6% from last quarter. Share price after the results: −11.2% in 30 days (Nifty 500: 0.0%).
  • Q4 FY26: Revenue ₹266 cr (+29% year on year), EBITDA ₹41.8 cr (+31% year on year), PAT ₹30.6 cr (+39% year on year), EBITDA margin 15.7% (+24 bps). Score 75 of 100, Above trend. Revenue growth was above the company's own trend; EBITDA and profit growth were in line with it. EBITDA margin rose 24 bps year on year. Revenue grew on the previous quarter, against its usual seasonal pattern. Share price after the results: +2.8% in 30 days (Nifty 500: +2.7%).
  • Q3 FY26: Revenue ₹225 cr (+31% year on year), EBITDA ₹37.7 cr (+45% year on year), PAT ₹22.7 cr (+42% year on year), EBITDA margin 16.7% (+161 bps). Score 65 of 100, Above trend. Revenue growth was above the company's own trend; EBITDA and profit growth were in line with it. EBITDA margin rose 161 bps year on year. Revenue rose ₹53.4 cr on a year ago, more than the ₹21.0 cr it added the year before. Share price after the results: −16.2% in 30 days (Nifty 500: −6.9%).
  • H1 FY26: Revenue ₹565 cr, EBITDA ₹94.0 cr, PAT ₹67.0 cr, EBITDA margin 16.6%. Not scored. No result for the same half-year last year. Share price after the results: −12.1% in 30 days (Nifty 500: −0.6%).
  • Q1 FY26: Revenue ₹275 cr (+25% year on year), EBITDA ₹45.0 cr (+61% year on year), PAT ₹35.0 cr (+84% year on year), EBITDA margin 16.4% (+364 bps). Score 76 of 100, Above trend. Revenue and profit growth were above the company's own trend; EBITDA growth was in line with it. EBITDA margin rose 364 bps year on year. Profit rose ₹16.0 cr on a year ago, more than the ₹4.0 cr it added the year before. Share price after the results: −7.4% in 29 days (Nifty 500: +0.6%).
  • Q4 FY25: Revenue ₹207 cr (+64% year on year), EBITDA ₹32.0 cr (+300% year on year), PAT ₹22.0 cr (+300% year on year), EBITDA margin 15.5% (+1,000 bps). Score 100 of 100, Above trend. Revenue, EBITDA and profit growth were well above the company's own trend. EBITDA margin rose 1000 bps year on year. Revenue grew on the previous quarter, against its usual seasonal pattern. Share price after the results: +29.7% in 30 days (Nifty 500: +1.7%).
  • Q3 FY25: Revenue ₹172 cr (+14% year on year), EBITDA ₹26.0 cr (−21% year on year), PAT ₹16.0 cr (−33% year on year), EBITDA margin 15.1% (−674 bps). Score 46 of 100, In line with trend. Revenue growth was above the company's own trend; EBITDA and profit growth were below it. EBITDA margin fell 674 bps year on year. Revenue fell 25% from last quarter.

Past price moves after results do not indicate future moves. Not a recommendation.

India Pesticides Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.